Skip to main content
Richard Aranda, MD, Gastroenterology, San Diego, CA

Richard Aranda MD


Chief Medical Officer, Gossamer Bio

Join to view full profile
  • 3033 Science Park Road#300San Diego, CA 92121

  • Phone+1 858-925-5519

Dr. Aranda is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1992 - 1995
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1986 - 1989
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1986

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • With GlaxoSmithKline in the Rearview Mirror, Abbas Hussain Is Ready to Lead a Biotech of His Own; Doug Treco Scores First CEO Job Since Ra Pharma Buyout
    With GlaxoSmithKline in the Rearview Mirror, Abbas Hussain Is Ready to Lead a Biotech of His Own; Doug Treco Scores First CEO Job Since Ra Pharma BuyoutJune 25th, 2021
  • The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
    The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing DealJune 22nd, 2021
  • The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
    The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing DealJune 22nd, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: